<VariationArchive RecordType="classified" VariationID="5057" VariationName="NM_018127.6(ELAC2):c.1641dup (p.His548Alafs)" VariationType="Duplication" Accession="VCV000005057" Version="1" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2013-04-04" MostRecentSubmission="2018-10-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20096" VariationID="5057">
      <GeneList>
        <Gene Symbol="ELAC2" FullName="elaC ribonuclease Z 2" GeneID="60528" HGNC_ID="HGNC:14198" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="12991612" stop="13018027" display_start="12991612" display_stop="13018027" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="12894928" stop="12921380" display_start="12894928" display_stop="12921380" Strand="-" />
          </Location>
          <OMIM>605367</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018127.6(ELAC2):c.1641dup (p.His548Alafs)</Name>
      <CanonicalSPDI>NC_000017.11:12996564:C:CC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17p12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="12996564" stop="12996565" display_start="12996564" display_stop="12996565" variantLength="1" positionVCF="12996564" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="12899881" stop="12899882" display_start="12899881" display_stop="12899882" variantLength="1" positionVCF="12899881" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>H508fs</ProteinChange>
      <ProteinChange>H547fs</ProteinChange>
      <ProteinChange>H548fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.12899882dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.12899882dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018127.7" sequenceAccession="NM_018127" sequenceVersion="7" change="c.1641dup" MANESelect="true">
            <Expression>NM_018127.7:c.1641dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060597.4" sequenceAccession="NP_060597" sequenceVersion="4" change="p.His548fs">
            <Expression>NP_060597.4:p.His548fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173717.2" sequenceAccession="NM_173717" sequenceVersion="2" change="c.1638dup">
            <Expression>NM_173717.2:c.1638dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_776065.1" sequenceAccession="NP_776065" sequenceVersion="1" change="p.His547fs">
            <Expression>NP_776065.1:p.His547fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.12996565dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.12996565dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015808.1" sequenceAccession="NG_015808" sequenceVersion="1" change="g.26500dup">
            <Expression>NG_015808.1:g.26500dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001165962.2" sequenceAccession="NM_001165962" sequenceVersion="2" change="c.1521dup">
            <Expression>NM_001165962.2:c.1521dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159434.1" sequenceAccession="NP_001159434" sequenceVersion="1" change="p.His508fs">
            <Expression>NP_001159434.1:p.His508fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA117234" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="605367.0003" DB="OMIM" />
        <XRef Type="rs" ID="387906327" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018127.6(ELAC2):c.1641dup (p.His548Alafs) AND Prostate cancer, hereditary, 2" Accession="RCV000005360" Version="2">
        <ClassifiedConditionList TraitSetID="8721">
          <ClassifiedCondition DB="MedGen" ID="C3539120">Prostate cancer, hereditary, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018127.6(ELAC2):c.1641dup (p.His548Alafs) AND Combined oxidative phosphorylation defect type 17" Accession="RCV000693905" Version="1">
        <ClassifiedConditionList TraitSetID="11994">
          <ClassifiedCondition DB="MedGen" ID="C3809526">Combined oxidative phosphorylation defect type 17</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-04-23" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-04-23" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2018-10-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">11175785</ID>
        </Citation>
        <DescriptionHistory Dated="2018-10-10">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="11994" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18309" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Combined oxidative phosphorylation deficiency 17</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Combined oxidative phosphorylation defect type 17</ElementValue>
                <XRef ID="MONDO:0014190" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COXPD17</ElementValue>
                <XRef Type="MIM" ID="615440" DB="OMIM" />
              </Symbol>
              <XRef ID="369913" DB="Orphanet" />
              <XRef ID="C3809526" DB="MedGen" />
              <XRef ID="MONDO:0014190" DB="MONDO" />
              <XRef Type="MIM" ID="615440" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8721" Type="Disease">
            <Trait ID="17316" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Prostate cancer, hereditary, 2</ElementValue>
                <XRef ID="MONDO:0013872" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPC2</ElementValue>
                <XRef Type="MIM" ID="614731" DB="OMIM" />
              </Symbol>
              <XRef ID="1331" DB="Orphanet" />
              <XRef ID="C3539120" DB="MedGen" />
              <XRef ID="MONDO:0013872" DB="MONDO" />
              <XRef Type="MIM" ID="614731" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="25538" SubmissionDate="2012-07-19" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="605367.0003_PROSTATE CANCER, HEREDITARY, 2" title="ELAC2, 1-BP, 1641G_PROSTATE CANCER, HEREDITARY, 2" />
        <ClinVarAccession Accession="SCV000025538" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Tavtigian et al. (2001) demonstrated an insertion/frameshift, 1641insG, in the ELAC2 gene in a Utah family with 8 prostate cancer cases (HPC2; 614731) in 3 generations. Insertion of a nucleotide between residues 1641 and 1642 shifted the reading frame after leu547, leading to termination after the miscoding of 67 residues. The mutation segregated with disease in this family.</Attribute>
              <Citation>
                <ID Source="PubMed">11175785</ID>
              </Citation>
              <XRef DB="OMIM" ID="614731" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ELAC2" />
          </GeneList>
          <Name>ELAC2, 1-BP, 1641G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP, 1641G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605367.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROSTATE CANCER, HEREDITARY, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1594079" SubmissionDate="2018-08-29" DateLastUpdated="2018-10-10" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="1525647|MedGen:C3809526" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000822328" DateUpdated="2018-10-10" DateCreated="2018-10-10" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>This sequence change creates a premature translational stop signal (p.His548Alafs*68) in the ELAC2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with ELAC2-related disease. ClinVar contains an entry for this variant (Variation ID: 5057). The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in ELAC2 cause disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ELAC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018127.6:c.1641dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Combined oxidative phosphorylation deficiency 17</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C3809526" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="25538" TraitType="Disease" MappingType="Name" MappingValue="PROSTATE CANCER, HEREDITARY, 2" MappingRef="Preferred">
        <MedGen CUI="C3539120" Name="Prostate cancer, hereditary, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1594079" TraitType="Disease" MappingType="Name" MappingValue="Combined oxidative phosphorylation deficiency 17" MappingRef="Preferred">
        <MedGen CUI="C3809526" Name="Combined oxidative phosphorylation defect type 17" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

